Life Sciences, Healthcare & IP Law
Bird & Bird LLP
Life at the interface of the Life Science and Healthcare sectors of the economy and law can appear to be confusing, even for the most seasoned operators and investors. Not so for Mark Hilton a partner and Co-Head at our firm of the International Life Sciences and Healthcare Group.
Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by the major global directories, such as Chambers, The Legal 500 and Who’s Who Law, as a top tier life sciences firm. Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment.
Our multidisciplinary team of 240 specialist life sciences experts means we are in pole-position to handle multijurisdictional matters, with offices across Europe, the Middle East and Asia. Technology is part of our DNA and firm’s strength in the technology sector, has allowed us to act at the very frontiers of the development of law and regulation surrounding such matters as Track and Trace apps. We also work with biotech clients in relation to novel gene therapies, biosimilars and Advanced Therapy Medicinal Products. Mark’s partner, Sally Shorthose, leads the regulatory practice, which has handled several pandemic-related matters, including the marketing of diagnostic test kits and the repurposing of factories to manufacture PPE and respiratory aids.
Our healthcare lawyers worldwide can advise you on every aspect of the investment and business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property. Many of our lawyers in this highly technical field have strong backgrounds in the life sciences, and bring with them industry-specific business knowledge to provide a complete commercial service to our clients.
We can advise you on:
- Technology transfers and IP Licensing
- R&D collaborations
- Patent and trade mark disputes and IP strategy
- Clinical trials
- Privacy and data protection
- Regulatory and data exclusivity
- Corporate transactions (including fundraising, IPOs and M&A)
- Competition law
- e-health, m-health and digitalisation
- Marketing arrangements and advertising
- Pricing and reimbursement
- Public procurement
- Taxes and allowances
- Product liability
- Employment issues
Mark’s work over the course of 20 years devoted to his clients in devising successful litigation and dispute strategies has enabled him to develop various state of the art IT solutions to improve information exchange and productivity in the sector. His and his Group’s expertise has earned them accolades from peers and clients alike. Here are some of their comments:
“Very accessible, always reachable, highly professional, enjoyable to work with.’ ‘Insightful regulatory advice based on in-depth industry knowledge and the highest standard of legal expertise.”
’ ‘Responsive, practical and commercial – the perfect business partner!’ ‘
“This practice is unique because they have such great experience and knowledge in such a large amount of localities. They are great to work with because they have very talented attorneys in lots of countries and can really help out international companies and support their growth.”
For CBD enquiries please contact in the first instance:
Sally Shorthose https://www.twobirds.com/en/people/s/sally-shorthose
James Baillieu https://www.twobirds.com/en/people/j/james-baillieu
For sanction queries please contact in the first instance:
Brian Mulier https://www.twobirds.com/en/people/b/brian-mulier
For further advice and assistance please contact:
020 7993 4255